Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| INTUIT INC. | 2,907 | reported | 23 Jan 2015 | tx 89+1,265,782−2,461,189 |
| Apple Inc. | 475 | reported | 28 Feb 2014 | tx 206+210,210−381,623 |
| OPSWARE INC | 0 | reported | 21 Sept 2007 | tx 14+93,451−275,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 23 Jan 2015 | GRANT_AWARD | INTUIT INC. | 2,907 | 0.00 USD | deriv |
| 28 Feb 2014 | GRANT_AWARD | Apple Inc. | 475 | 0.00 USD | deriv |
| 01 Feb 2014 | EXERCISE | Apple Inc. | 562 | — | |
| 01 Feb 2014 | EXERCISE | Apple Inc. | 562 | — | deriv |
| 24 Jan 2014 | GRANT_AWARD | INTUIT INC. | 3,550 | 0.00 USD | deriv |
| 29 Jul 2013 | SALE | Apple Inc. | 7,229 | 440.35 USD | |
| 29 Jul 2013 | SALE | Apple Inc. | 2,771 | 441.86 USD | |
| 29 Jul 2013 | EXERCISE | Apple Inc. | 10,000 | 10.19 USD | |
| 29 Jul 2013 | EXERCISE | Apple Inc. | 10,000 | 0.00 USD | deriv |
| 27 Feb 2013 | GRANT_AWARD | Apple Inc. | 562 | 0.00 USD | deriv |
| 01 Feb 2013 | EXERCISE | Apple Inc. | 387 | — | |
| 01 Feb 2013 | EXERCISE | Apple Inc. | 387 | — | deriv |
| 18 Jan 2013 | GRANT_AWARD | INTUIT INC. | 4,083 | 0.00 USD | deriv |
| 01 Jan 2013 | TAX_WITHHOLDING | INTUIT INC. | 868 | 59.48 USD | |
| 01 Jan 2013 | EXERCISE | INTUIT INC. | 1,854 | 0.00 USD | |
| 01 Jan 2013 | EXERCISE | INTUIT INC. | 1,854 | 0.00 USD | deriv |
| 30 Jul 2012 | EXERCISE | Apple Inc. | 10,000 | 7.00 USD | |
| 30 Jul 2012 | SALE | Apple Inc. | 2,100 | 588.85 USD | |
| 30 Jul 2012 | SALE | Apple Inc. | 3,789 | 590.24 USD | |
| 30 Jul 2012 | SALE | Apple Inc. | 4,111 | 591.32 USD | |
| 30 Jul 2012 | EXERCISE | Apple Inc. | 10,000 | 0.00 USD | deriv |
| 23 Feb 2012 | GRANT_AWARD | Apple Inc. | 387 | 0.00 USD | deriv |
| 01 Feb 2012 | EXERCISE | Apple Inc. | 584 | — | |
| 01 Feb 2012 | EXERCISE | Apple Inc. | 584 | — | deriv |
| 20 Jan 2012 | GRANT_AWARD | INTUIT INC. | 4,554 | 0.00 USD | deriv |